|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61K 31/4709 | (2006.01) |
| A61K 31/704 | (2006.01) | ||
| A61K 31/7016 | (2006.01) | ||
| A61K 31/198 | (2006.01) | ||
| A61K 31/201 | (2006.01) | ||
| A61K 31/353 | (2006.01) | ||
| A61K 31/155 | (2006.01) | ||
| A61K 31/7032 | (2006.01) | ||
| A61K 31/194 | (2006.01) | ||
| A61K 31/575 | (2006.01) | ||
| A61P 7/12 | (2006.01) | ||
| A61P 3/04 | (2006.01) | ||
| A61P 3/00 | (2006.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 19/10 | (2006.01) | ||
| A61P 21/00 | (2006.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61P 1/00 | (2006.01) | ||
| A61P 25/24 | (2006.01) |
| (11) | Patento numeris | 2661266 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12732408.5 |
| Europos patento paraiškos padavimo data | 2012-01-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-11-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-09-16 |
| (46) | Apibrėžties vertimo paskelbimo data | 2020-12-10 |
| (86) | Numeris | PCT/US2012/020548 |
| Data | 2012-01-06 |
| (87) | Numeris | WO 2012/094636 |
| Data | 2012-07-12 |
| (30) | Numeris | Data | Šalis |
| 201161430914 P | 2011-01-07 | US |
| (72) |
BARON, Alain D., US
BROWN, Martin R., US
JONES, Christopher R. G., US
BEELEY, Nigel R. A., US
FINEMAN, Mark S., US
|
| (73) |
Anji Pharma (US) LLC,
4 Dana Road, Boxford, MA 01921,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Gydimo būdai chemosensorinio receptoriaus ligando pagrindu |
| CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-11-21 | 15 | 289.00 EUR |
| 2027-01-06 |